Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from National Research ( (NRC) ).
On April 27, 2026, NRC Health’s Compensation and Talent Committee amended previously granted stock awards to CEO Trent Green, COO and EVP Helen Hrdy, and Chief Corporate Development Officer and EVP Andrew Monich, originally issued in 2025 to create fully vested, meaningful stock ownership that mirrored non-management shareholders’ economic experience. The Committee removed the company’s right to repurchase shares at $1.00 upon certain terminations within three years and approved cash bonuses of about $1.9 million for Green and about $0.5 million each for Hrdy and Monich to cover estimated tax liabilities arising from the amendments and bonuses.
These changes are expected to generate approximately $9.4 million of expense in the second quarter of 2026, including about $6.5 million of non-cash accelerated equity compensation expense that would otherwise have been recognized through the second quarter of 2028 and about $2.9 million of cash bonus expense tied largely to tax payments. The non-deductibility of these amounts is expected to affect NRC Health’s effective tax rate for the second quarter and the remainder of 2026, while the accelerated recognition of equity compensation expense removes the impact of these awards from future periods.
Spark’s Take on NRC Stock
According to Spark, TipRanks’ AI Analyst, NRC is a Neutral.
The score is held back primarily by weakening financial trajectory (revenue decline, margin compression) and elevated leverage, despite continued cash generation. Offsetting factors include favorable technical momentum and a supportive earnings narrative pointing to a 2026 growth inflection driven by improving recurring contract value and sales/retention trends, though the high P/E limits the valuation score.
To see Spark’s full report on NRC stock, click here.
More about National Research
NRC Health operates in the healthcare data and patient experience industry, providing measurement, analytics, and related services to help healthcare providers understand and improve patient satisfaction and engagement. Its business model focuses on aligning leadership incentives with shareholder interests through equity-based compensation and long-term ownership.
Average Trading Volume: 106,497
Technical Sentiment Signal: Hold
Current Market Cap: $391.9M
Find detailed analytics on NRC stock on TipRanks’ Stock Analysis page.